RYN logo

Rayonier Inc. REIT (RYN)

$18.75

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on RYN

Market cap

$5.58B

EPS

0.43

P/E ratio

44.1

Price to sales

5.83

Dividend yield

5.547%

Beta

0.905248

Price on RYN

Previous close

$19.22

Today's open

$19.13

Day's range

$18.63 - $19.29

52 week range

$17.71 - $24.82

Profile about RYN

CEO

Mark Mchugh

Employees

424

Headquarters

WILDLIGHT, FL

Exchange

New York Stock Exchange

Shares outstanding

297567291

Issue type

Common Stock

RYN industries and sectors

Real Estate

REITs

News on RYN

Earnings Preview: Rayonier (RYN) Q3 Earnings Expected to Decline

Rayonier (RYN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

news source

Zacks Investment Research • Oct 28, 2026

news preview

Forget Apartments and Offices: These 4 REITs Own Casinos, Forests and Farms

Casino landlords, timberland owners, and farm operators all collect rent in wildly different ways, and only one of these four specialty REITs has a dividend that its own earnings guidance can actually cover.

news source

24/7 Wall Street • Oct 27, 2026

news preview

Rayonier Announces Fourth Quarter 2026 Dividend

WILDLIGHT, Fla.--(BUSINESS WIRE)--Rayonier Inc. (NYSE:RYN) announced today that the Company's board of directors has declared a fourth quarter cash dividend of $0.26 per common share. The dividend is payable on December 31, 2026, to shareholders of record on December 17, 2026. The Company also announced today that the Company's board of directors, in its capacity as the board of directors of the general partner of Rayonier, L.P., has declared a fourth quarter cash distribution of $0.26 per oper.

news source

Business Wire • Oct 16, 2026

news preview

Rayonier: Significant Land Discount Drives A Buy, But Dividend Quality Bears Watching

Rayonier is rated Buy with a $23.04 target, driven by asset value and a 5.5% dividend yield, over an 18–24 month horizon. My thesis emphasizes monetization of land, merger integration, and prudent NAV adjustments, rather than relying on a lumber sector rebound. Merger integration is key; $40 million in annual synergies are a goal, not a realized benefit, with cost reduction and cash conversion as priorities.

news source

Seeking Alpha • Oct 14, 2026

news preview

Rayonier Scheduled to Release Third Quarter Earnings on November 4

WILDLIGHT, Fla.--(BUSINESS WIRE)--Rayonier Inc. (NYSE:RYN) plans to release its third quarter 2026 earnings after the market closes on Wednesday, November 4, 2026.Rayonier will host a conference call and live audio webcast at 10:00 a.m. (ET) on Thursday, November 5 to discuss these results. Supplemental materials and access to the live audio webcast will be available at www.rayonier.com. A replay of the webcast will be archived on the Company's website and available shortly after the call.The co.

news source

Business Wire • Oct 14, 2026

news preview

Longleaf Partners Fund Q3 2026 Portfolio Review

The market is regaining confidence in Avantor's ability to grow organically and in Emmanuel Ligner's turnaround plan. Biopharma company Regeneron reported a solid set of results, with key drug Dupixent continuing to outpace our and the market's growth expectations. Building products company Fortune Brands Innovations saw its stock price decline in Q3, retracing Q2's positive move related to excitement over Jesse Singh's appointment as CEO.

news source

Seeking Alpha • Oct 14, 2026

news preview

Longleaf Partners Small-Cap Fund Q3 2026 Portfolio Review

Packaging company Clearwater Paper was a contributor in the quarter. Alaskan cable company Liberty Capital was a contributor in the quarter. Empire State Realty's underperformance this quarter was mostly driven by its Empire State Building Observatory hitting a rough patch over the last two years. Broadband operator Shenandoah Telecommunications was a contributor for us in the first half of the year but detracted in the third quarter.

news source

Seeking Alpha • Oct 14, 2026

news preview

Longleaf Partners Global Fund Q3 2026 Portfolio Review

Biopharma company Regeneron reported a solid set of results, with key drug Dupixent continuing to outpace our and the market's growth expectations. In the first part of the year before we invested, Abbott slightly missed earnings estimates while it was digesting its acquisition of Exact Sciences, along with a variety of turmoil in the medtech and infant nutrition industries. Digital and print publisher People Inc. was a detractor in the quarter, while hospitality and entertainment company MGM Resorts also detracted.

news source

Seeking Alpha • Oct 14, 2026

news preview

Mr. Market Can't See The Forest For The Trees (2 Beaten-Down Timber REITs)

Weyerhaeuser and Rayonier present compelling value after recent share price weakness, with compressed valuations and attractive dividend yields. WY offers integrated scale, manufacturing leverage, and embedded land optionality, while RYN provides Southern land exposure and development opportunities post-PotlatchDeltic merger. Intrinsic value analysis and normalized Price-to-EBITDA suggest potential upside, but margin of safety depends on conservative asset, earnings, and leverage assumptions.

news source

Seeking Alpha • Oct 4, 2026

news preview

The Next Big Move In Interest Rates: How I'm Buying The Dividend Sell-Off

Dividend stocks are under pressure from rising long-term interest rates. What matters most in the near term is where interest rates are headed next. I detail the factors at play and where I think the best risk-adjusted places to allocate capital today are.

news source

Seeking Alpha • Oct 3, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Rayonier Inc. REIT

Open an M1 investment account to buy and sell Rayonier Inc. REIT commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in RYN on M1